Bypass and Beyond: Redefining Roles and Mechanisms of Obesity Treatment at ENDO 2025
Easy Targets: How Endocrine-Disrupting Chemicals Affect Reproductive Endocrinology
Endocrine-disrupting chemicals have been implicated in a wide range of poor health outcomes, including infertility and obesity. Endocrine News speaks to Almudena Veiga-Lopez, DVM, PhD, the chair of an upcoming ENDO 2025 symposium on these chemicals’ effects on reproductive organs, which are particularly vulnerable to EDCs. Endocrine-disrupting chemicals are everywhere, and there is seemingly no...Sriram Gubbi of NIDDK Wins Endocrine Society’s 2025 Endocrine Images Art Competition
“Cosmic Bubble” image features cells from a thyroid cancer subtype Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”. The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...Weighing In: Making Obesity Treatment More Effective and Accessible by 2030
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...Harsh Realities: How Treating Obesity Across the Lifespan Continues to Evolve
As the Endocrine Society prepares to welcome the endocrinology world to Boston from ENDO 2024, Endocrine News is once again highlighting our host city’s local flair, with some conference highlights as well. Plus, we’ve got recommendations from some of your in-the-know colleagues! Boston may be one of America’s most historic cities, but it’s far from...
